The European Medicines Agency has authorised the use of Pfizer-BioNTech’s COVID-19 vaccine among kids between ages of 5 and 11. The jab, currently known by its trade name Comirnaty, will be given through two doses three weeks apart but at a lower dose.
With the Pfizer vaccine already authorised for use in people aged 12 and above and the main one used in Malta’s vaccination programme, the introduction of Comirnaty can help spread further immunity.The EMA issued a statement on Thursday, saying that ‘the efficacy of Comirnaty was calculated in almost 2,000 children from 5 to 11 years of age who had no sign of previous infection.’
Health Minister Chris Fearne revealed that the health authorities were in a position to start delivering Comirnaty to kids starting mid-December. The most common side effects in children in this approved age group are similar to those observed anyone over the age of 12. The side-effects, which include tiredness, headaches and possible swelling, improve within a few days of vaccination and are usually mild or moderate.
#MaltaDaily
Photo Source: Chris Fearne FB, Daily Sabah, CBC